Results 11 to 20 of about 324,334 (253)

Barriers and facilitators to prescribing medicinal cannabis in New Zealand [PDF]

Journal of Primary Health Care, 2023
Introduction The New Zealand Medicinal Cannabis Scheme (NZMCS) was established in April 2020 with the aim of expanding access to quality controlled medicinal cannabis products and developing a domestic medicinal cannabis industry.
Chris Wilkins, Marta Rychert, Vinuli Withanarachchie   +2 more
doaj   +3 more sources

Cannabis Medicinal: Investigaciones colaborativas de las ciencias sociales [PDF]

, 2023
Este artículo presenta la labor realizada por la Comisión de Ciencias Sociales de la Red de Cannabis de Uso Medicinal e Industrial del CONICET (RACME), integrada por investigadorxs, representantes de ONG, profesionales y docentes.
Aguirre, Roxana, Calzolary, Gabriela, Romero, Lucia Ana, Pimpinella, Sabrina, Díaz, María Cecilia, Pedrana, María Soledad, Corbelle, Florencia   +6 more
core   +2 more sources

‘A glimmer of hope’: perceptions, barriers, and drivers for medicinal cannabis use amongst Australian and New Zealand people with endometriosis – a qualitative study

Reproduction and Fertility, 2023
Previous quantitative research has shown that cannabis use, mostly illicit, is used for symptom management amongst those with endometriosis living in Australia or New Zealand, but the drivers and barriers for use of legal, medicinal cannabis in this ...
Justin Sinclair, Jason Abbott, Antonina Mikocka-Walus, Cecilia Ng, Jerome Sarris, Subhadra Evans, Mike Armour   +6 more
doaj   +1 more source

Implementation of medicinal cannabis in Australia: innovation or upheaval? Perspectives from physicians as key informants, a qualitative analysis

BMJ Open, 2021
Objective We sought to explore physician perspectives on the prescribing of cannabinoids to patients to gain a deeper understanding of the issues faced by prescriber and public health advisors in the rollout of medicinal cannabis.Design A thematic ...
Christine Mary Hallinan, Jane Maree Gunn, Yvonne Ann Bonomo   +2 more
doaj   +1 more source

Views on and experiences with medicinal cannabis among Canadian veterans who live with pain: A qualitative study

Canadian Journal of Pain, 2023
Background During fiscal year 2021–2022, Veterans Affairs Canada (VAC) reimbursed 18,388 veterans for medicinal cannabis at a cost of $153 million. Yet, it is not known whether the reimbursement program is producing a net benefit for veterans.Aims This ...
David P. Storey, Natalie R. Keeler-Villa, Nick Harris, Jennifer Anthonypillai, Gregory K. Tippin, Vikas Parihar, Joshua A. Rash   +6 more
doaj   +1 more source

Medicinal cannabis for the treatment of anxiety disorders. [PDF]

, 2022
BACKGROUND Anxiety is second most common reason for medicinal cannabis prescription in Australia and is being treated with both Δ9-tetrahydrocannabinol (THC)-containing and cannabidiol (CBD)-dominant products.
Berger, Maximus, Maximus Berger, Iain S McGregor, Amminger, G Paul, McGregor, Iain S, G Paul Amminger   +5 more
core   +1 more source

Medicinal Cannabis and Central Nervous System Disorders

Frontiers in Pharmacology, 2022
Cannabinoids, including those found in cannabis, have shown promise as potential therapeutics for numerous health issues, including pathological pain and diseases that produce an impact on neurological processing and function.
Yuma T. Ortiz, Lance R. McMahon, Jenny L. Wilkerson   +2 more
doaj   +1 more source

Brief interventions for cannabis use in emerging adults: protocol for a systematic review, meta-analysis, and evidence map

Systematic Reviews, 2018
Background Rates of cannabis use are highest during emerging adulthood (age 18–25), with the prevalence of near daily and daily increasing among this age group.
Jillian Halladay, Tashia Petker, Allan Fein, Catharine Munn, James MacKillop   +4 more
doaj   +1 more source

Using Social Media Data to Investigate Public Perceptions of Cannabis as a Medicine: Narrative Review

Journal of Medical Internet Research, 2023
BackgroundThe use and acceptance of medicinal cannabis is on the rise across the globe. To support the interests of public health, evidence relating to its use, effects, and safety is required to match this community demand.
Sedigh Khademi, Christine Mary Hallinan, Mike Conway, Yvonne Bonomo   +3 more
doaj   +1 more source

The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists' Perspectives. [PDF]

PLoS ONE, 2016
BACKGROUND:Medicinal cannabis has recently attracted much media attention in Australia and across the world. With the exception of a few countries, cannabinoids remain illegal-known for their adverse effects rather than their medicinal application and ...
Sami Isaac, Bandana Saini, Betty B Chaar
doaj   +1 more source